CIK 0000200406 · Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221024240
- Phone
- 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,898,386
- in 3 filings
Net −$16,898,386. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-18 | Duato Joaquin CEO and Chairman of the Board | Gift | +130,852 | 130,852 | ||
| 2025-03-04 | HEWSON MARILLYN A Director | Grant or award · Deferred Share Units | +75.26 | $166.10 | $13K | 14,306.45 |
| 2025-03-04 | HEWSON MARILLYN A Director | Grant or award · Deferred Share Units | +225.77 | $166.10 | $38K | 11,690.95 |
| 2025-03-04 | Woods Eugene A. Director | Grant or award · Deferred Share Units | +188.14 | $166.10 | $31K | 3,013.66 |
| 2025-02-25 | Decker Robert J VP Corporate Controller | Option exercise | +6,999 | $101.87 | $713K | 28,000 |
| 2025-02-25 | Decker Robert J VP Corporate Controller | Sale | −6,999 | $165.88 | $1.2M | 21,001 |
| 2025-02-25 | Decker Robert J VP Corporate Controller | Option exercise · Employee Stock Options (Right to Buy) | −6,999 | $101.87 | $713K | 0 |
| 2025-02-18 | Schmid Timothy EVP, WW Chair, MedTech | Sale | −403 | $156.15 | $63K | 15,098 |
| 2025-02-18 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Shares withheld for taxes | −200 | $156.15 | $31K | 90,836.87 |
| 2025-02-18 | Wolk Joseph J Exec VP, CFO | Shares withheld for taxes | −768 | $156.15 | $120K | 5,345 |
| 2025-02-15 | Wolk Joseph J Exec VP, CFO | Grant or award · Employee Stock Options (Right to Buy) | +91,277 | 91,277 | ||
| 2025-02-15 | Wolk Joseph J Exec VP, CFO | Grant or award · Restricted Share Units | +5,632 | 5,632 | ||
| 2025-02-15 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Grant or award · Employee Stock Options (Right to Buy) | +30,841 | 30,841 | ||
| 2025-02-15 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Grant or award · Restricted Share Units | +1,903 | 1,903 | ||
| 2025-02-15 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Grant or award · Employee Stock Options (Right to Buy) | +89,781 | 89,781 | ||
| 2025-02-15 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Grant or award · Restricted Share Units | +5,539 | 5,539 | ||
| 2025-02-15 | Swanson James D. EVP, CIO | Grant or award · Employee Stock Options (Right to Buy) | +34,476 | 34,476 | ||
| 2025-02-15 | Swanson James D. EVP, CIO | Grant or award · Restricted Share Units | +2,127 | 2,127 | ||
| 2025-02-15 | Schmid Timothy EVP, WW Chair, MedTech | Grant or award · Employee Stock Options (Right to Buy) | +49,878 | 49,878 | ||
| 2025-02-15 | Schmid Timothy EVP, WW Chair, MedTech | Grant or award · Restricted Share Units | +3,077 | 3,077 |
Page 16 of 19 · 365 trades